United States Biotechnology & Medical Research

Rapport Therapeutics Inc (RAPP)

Track

Over the past 90 days, Rapport Therapeutics Inc. insiders have executed 21 transactions, all of which were sales totaling approximately $40.2 million. Key executives, including the CEO and COO, along with major shareholders like Third Rock Ventures, have conducted these planned and proposed sales. These activities follow a period where the stock price rose 20.8%.
Ticker: RAPP Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Rapport Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Planned sale 27 Jul 2026
Value US$1,335,715.73 | Price 93.58 | Shares 82,401 (+49.3%)
Planned sale 27 Jul 2026
Value US$2,737,243.85 | Price 283.55 | Shares 89,762 (-49.0%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-29 2026-07-27 PlS Planned sale
Ceesay Abraham

Chief Executive Officer

Executive Director
82,401 +49.3%
93.58
US$1,335,716 		82,401 +49.3% 93.58 US$1,335,716
2026-07-29 2026-07-27 PlS Planned sale
Ceesay Abraham

Chief Executive Officer

Executive Director
89,762 -49.0%
283.55
US$2,737,244 		89,762 -49.0% 283.55 US$2,737,244
2026-07-15 2026-07-14 PlS Planned sale
Ceesay Abraham

Chief Executive Officer

Executive Director
54,626 +33.7%
264.65
US$3,948,285 		54,626 +33.7% 264.65 US$3,948,285
2026-07-15 2026-07-14 PlS Planned sale
Ceesay Abraham

Chief Executive Officer

Executive Director
5,481 -1.0%
39.72
US$217,715 		5,481 -1.0% 39.72 US$217,715
2026-07-01 2026-06-30 PlS Planned sale
0.6
Gault Cheryl

Chief Operating Officer

Officer
1,000 -0.7%
43.15
US$43,155 		1,000 -0.7% 43.15 US$43,155
2026-07-01 2026-06-30 PlS Planned sale
0.6
Gault Cheryl

Chief Operating Officer

Officer
3,308 -2.1%
42.17
US$139,506 		3,308 -2.1% 42.17 US$139,506
2026-07-01 2026-06-30 PlS Planned sale
0.6
Gault Cheryl

Chief Operating Officer

Officer
3,792 -2.4%
41.39
US$156,964 		3,792 -2.4% 41.39 US$156,964
2026-07-01 2026-06-30 PlS Planned sale
0.6
Gault Cheryl

Chief Operating Officer

Officer
1,900 -1.2%
40.09
US$76,174 		1,900 -1.2% 40.09 US$76,174
2026-06-30 2026-06-30 PrS Proposed sale
0.6
CHERYL GAULT

Officer

Officer
10,000
40.39
US$403,900 		10,000 40.39 US$403,900
2026-07-01 2026-06-29 PlS Planned sale
Ceesay Abraham

Chief Executive Officer

Executive Director
876 -0.2%
40.34
US$35,336 		876 -0.2% 40.34 US$35,336
2026-07-01 2026-06-29 PlS Planned sale
Ceesay Abraham

Chief Executive Officer

Executive Director
7,344 -1.3%
39.77
US$292,062 		7,344 -1.3% 39.77 US$292,062
2026-06-29 2026-06-29 PrS Proposed sale
Abraham N. Ceesay

Officer

Officer
99,480
40.39
US$4,017,997 		99,480 40.39 US$4,017,997
2026-05-28 2026-05-26 PlS Planned sale
3.2
Third Rock Ventures V, L.P.
Large shareholder
18,572 -0.3%
40.05
US$743,753 		18,572 -0.3% 40.05 US$743,753
2026-05-27 2026-05-26 PrS Proposed sale
3.2
Third Rock Ventures V, L.P.

10% Stockholder

Large shareholder
18,572
40.00
US$742,880 		18,572 40.00 US$742,880
2026-05-13 2026-05-11 PlS Planned sale
3.2
Third Rock Ventures V, L.P.
Large shareholder
133,618 -2.1%
40.24
US$5,377,323 		133,618 -2.1% 40.24 US$5,377,323
2026-05-11 2026-05-11 PrS Proposed sale
3.2
Third Rock Ventures V, L.P.

10% Stockholder

Large shareholder
133,618
40.25
US$5,378,124 		133,618 40.25 US$5,378,124
2026-05-11 2026-05-08 PlS Planned sale
3.2
Third Rock Ventures V, L.P.
Large shareholder
5,018 -0.1%
40.31
US$202,256 		5,018 -0.1% 40.31 US$202,256
2026-05-08 2026-05-08 PrS Proposed sale
3.2
Third Rock Ventures V, L.P.

10% Stockholder

Large shareholder
5,018
40.31
US$202,254 		5,018 40.31 US$202,254
2026-05-08 2026-05-08 PrS Proposed sale
3.2
Third Rock Ventures V, L.P.

10% Stockholder

Large shareholder
5,018
40.31
US$202,254 		5,018 40.31 US$202,254
2026-05-11 2026-05-07 PlS Planned sale
3.2
Third Rock Ventures V, L.P.
Large shareholder
271,495 -4.0%
40.12
US$10,892,651 		271,495 -4.0% 40.12 US$10,892,651
2026-05-07 2026-05-07 PrS Proposed sale
3.2
Third Rock Ventures V, L.P.

10% Stockholder

Large shareholder
271,495
40.12
US$10,892,705 		271,495 40.12 US$10,892,705
2026-04-21 2026-04-17 PlS Planned sale
3.2
Third Rock Ventures V, L.P.
Large shareholder
426,005 -6.0%
40.32
US$17,175,244 		426,005 -6.0% 40.32 US$17,175,244
2026-04-21 2026-04-17 PlS Planned sale
1.7
Yeleswaram Krishnaswamy

Chief Development Officer

Officer
20,225 -7.6%
39.99
US$808,844 		20,225 -7.6% 39.99 US$808,844
2026-04-17 2026-04-17 PrS Proposed sale
1.7
KRISHNASWAMY YELESWARAM

Officer

Officer
20,225
39.54
US$799,696 		20,225 39.54 US$799,696
2026-04-17 2026-04-17 PrS Proposed sale
3.2
Third Rock Ventures V, L.P.

10% Stockholder

Large shareholder
426,005
40.32
US$17,175,116 		426,005 40.32 US$17,175,116
2026-04-14 2026-04-14 PlS Planned sale
1.7
Yeleswaram Krishnaswamy

Chief Development Officer

Officer
10,200 -3.7%
35.08
US$357,797 		10,200 -3.7% 35.08 US$357,797
2026-04-14 2026-04-13 PlS Planned sale
1.7
Yeleswaram Krishnaswamy

Chief Development Officer

Officer
9,165 -3.2%
34.97
US$320,537 		9,165 -3.2% 34.97 US$320,537
2026-04-13 2026-04-13 PrS Proposed sale
1.7
KRISHNASWAMY YELESWARAM

Officer

Officer
19,365
34.17
US$661,702 		19,365 34.17 US$661,702
2026-04-14 2026-04-10 PlS Planned sale
1.7
Yeleswaram Krishnaswamy

Chief Development Officer

Officer
500 -0.2%
34.98
US$17,490 		500 -0.2% 34.98 US$17,490
2026-04-10 2026-04-10 PrS Proposed sale
1.7
KRISHNASWAMY YELESWARAM

Officer

Officer
500
34.22
US$17,110 		500 34.22 US$17,110
2026-04-09 2026-04-08 PlS Planned sale
1.7
Yeleswaram Krishnaswamy

Chief Development Officer

Officer
360 -0.1%
34.90
US$12,564 		360 -0.1% 34.90 US$12,564
2026-04-08 2026-04-08 PrS Proposed sale
1.7
KRISHNASWAMY YELESWARAM

Officer

Officer
360
33.49
US$12,056 		360 33.49 US$12,056
2026-03-31 2026-03-30 PlS Planned sale
0.6
Gault Cheryl

Chief Operating Officer

Officer
2,839 -1.7%
28.55
US$81,062 		2,839 -1.7% 28.55 US$81,062
2026-03-31 2026-03-30 PlS Planned sale
0.6
Gault Cheryl

Chief Operating Officer

Officer
7,161 -4.2%
28.04
US$200,795 		7,161 -4.2% 28.04 US$200,795
2026-03-30 2026-03-30 PrS Proposed sale
0.6
CHERYL GAULT

Officer

Officer
10,000
27.84
US$278,400 		10,000 27.84 US$278,400
2026-03-26 2026-03-25 PlS Planned sale
1.7
Yeleswaram Krishnaswamy

Chief Development Officer

Officer
10,115 -3.4%
29.99
US$303,355 		10,115 -3.4% 29.99 US$303,355
2026-03-25 2026-03-25 PrS Proposed sale
1.7
KRISHNASWAMY YELESWARAM

Officer

Officer
10,115
28.25
US$285,749 		10,115 28.25 US$285,749
2026-03-09 2026-03-05 S Sale
0.6
Gault Cheryl

Chief Operating Officer

Officer
2,014 -1.2%
28.93
US$58,265 		2,014 -1.2% 28.93 US$58,265
2026-03-05 2026-03-05 PrS Proposed sale
0.6
Gault Cheryl

Officer

Officer
2,014
28.92
US$58,236 		2,014 28.92 US$58,236
2026-02-19 2026-02-18 PlS Planned sale
Ceesay Abraham

Chief Executive Officer

Executive Director
2,100 -9.2%
29.80
US$62,573 		2,100 -9.2% 29.80 US$62,573
2026-02-19 2026-02-18 PlS Planned sale
Ceesay Abraham

Chief Executive Officer

Executive Director
2,983 -11.6%
29.04
US$86,639 		2,983 -11.6% 29.04 US$86,639
2026-02-19 2026-02-18 PlS Planned sale
Ceesay Abraham

Chief Executive Officer

Executive Director
2,281 -0.4%
29.80
US$67,970 		2,281 -0.4% 29.80 US$67,970
2026-02-19 2026-02-18 PlS Planned sale
Ceesay Abraham

Chief Executive Officer

Executive Director
3,552 -0.6%
29.05
US$103,191 		3,552 -0.6% 29.05 US$103,191
2026-02-19 2026-02-17 PlS Planned sale
1.7
Bredt David

Chief Scientific Officer

Officer
2,200 -0.6%
29.59
US$65,108 		2,200 -0.6% 29.59 US$65,108
2026-02-19 2026-02-17 PlS Planned sale
1.7
Bredt David

Chief Scientific Officer

Officer
5,400 -1.4%
28.95
US$156,328 		5,400 -1.4% 28.95 US$156,328
2026-02-19 2026-02-17 PlS Planned sale
1.7
Bredt David

Chief Scientific Officer

Officer
900 -0.2%
28.02
US$25,219 		900 -0.2% 28.02 US$25,219
2026-01-22 2026-01-20 PlS Planned sale
Ceesay Abraham

Chief Executive Officer

Executive Director
5,083 -16.5%
26.11
US$132,737 		5,083 -16.5% 26.11 US$132,737
2026-01-22 2026-01-20 PlS Planned sale
Ceesay Abraham

Chief Executive Officer

Executive Director
5,833 -1.0%
26.12
US$152,333 		5,833 -1.0% 26.12 US$152,333
2026-01-16 2026-01-15 PlS Planned sale
1.7
Bredt David

Chief Scientific Officer

Officer
200 -0.1%
27.40
US$5,480 		200 -0.1% 27.40 US$5,480
2026-01-16 2026-01-15 PlS Planned sale
1.7
Bredt David

Chief Scientific Officer

Officer
8,300 -2.1%
26.83
US$222,652 		8,300 -2.1% 26.83 US$222,652
2026-01-15 2026-01-15 PrS Proposed sale
1.7
DAVID BREDT

Officer

Officer
17,000
27.42
US$466,140 		17,000 27.42 US$466,140
2026-01-02 2026-01-02 PrS Proposed sale
1.7
DAVID BREDT

Officer

Officer
6,567
30.05
US$197,338 		6,567 30.05 US$197,338
2026-01-02 2026-01-02 PrS Proposed sale
1.7
Krishnaswamy Yeleswaram

Officer

Officer
2,840
30.05
US$85,343 		2,840 30.05 US$85,343
2026-01-05 2025-12-31 S Sale
1.7
Bredt David

Chief Scientific Officer

Officer
6,567 -1.6%
30.05
US$197,338 		6,567 -1.6% 30.05 US$197,338
2026-01-05 2025-12-31 S Sale
1.7
Yeleswaram Krishnaswamy

Chief Development Officer

Officer
2,840 -0.9%
30.05
US$85,342 		2,840 -0.9% 30.05 US$85,342
2025-12-18 2025-12-17 PlS Planned sale
Ceesay Abraham

Chief Executive Officer

Executive Director
515 -1.6%
31.04
US$15,985 		515 -1.6% 31.04 US$15,985
2025-12-18 2025-12-17 PlS Planned sale
Ceesay Abraham

Chief Executive Officer

Executive Director
2,421 -7.2%
30.04
US$72,722 		2,421 -7.2% 30.04 US$72,722
2025-12-18 2025-12-17 PlS Planned sale
Ceesay Abraham

Chief Executive Officer

Executive Director
2,147 -6.0%
28.84
US$61,925 		2,147 -6.0% 28.84 US$61,925
2025-12-18 2025-12-17 PlS Planned sale
Ceesay Abraham

Chief Executive Officer

Executive Director
600 -0.1%
31.04
US$18,622 		600 -0.1% 31.04 US$18,622
2025-12-18 2025-12-17 PlS Planned sale
Ceesay Abraham

Chief Executive Officer

Executive Director
2,792 -0.5%
30.04
US$83,862 		2,792 -0.5% 30.04 US$83,862
2025-12-18 2025-12-17 PlS Planned sale
Ceesay Abraham

Chief Executive Officer

Executive Director
2,441 -0.4%
28.84
US$70,393 		2,441 -0.4% 28.84 US$70,393
2025-12-17 2025-12-17 PrS Proposed sale
THE DOROTHY CEESAY IRREVOCABLE TRUST

Director; Officer

Executive Director
15,249
30.76
US$469,059 		15,249 30.76 US$469,059
2025-12-17 2025-12-17 PrS Proposed sale
ABRAHAM CEESAY

Director; Officer

Executive Director
17,499
30.76
US$538,269 		17,499 30.76 US$538,269
2025-12-16 2025-12-15 PlS Planned sale
1.7
Bredt David

Chief Scientific Officer

Officer
796 -0.2%
30.68
US$24,419 		796 -0.2% 30.68 US$24,419
2025-12-16 2025-12-15 PlS Planned sale
1.7
Bredt David

Chief Scientific Officer

Officer
7,704 -1.9%
29.95
US$230,711 		7,704 -1.9% 29.95 US$230,711
2025-12-01 2025-11-26 PlS Planned sale
0.6
Gault Cheryl

Chief Operating Officer

Officer
5,000 -2.8%
30.10
US$150,486 		5,000 -2.8% 30.10 US$150,486
2025-11-18 2025-11-17 PlS Planned sale
1.7
Bredt David

Chief Scientific Officer

Officer
5,344 -1.3%
25.39
US$135,696 		5,344 -1.3% 25.39 US$135,696
2025-11-18 2025-11-17 PlS Planned sale
1.7
Bredt David

Chief Scientific Officer

Officer
3,156 -0.8%
24.84
US$78,395 		3,156 -0.8% 24.84 US$78,395
2025-11-18 2025-11-17 PlS Planned sale
Ceesay Abraham

Chief Executive Officer

Executive Director
2,841 -7.3%
25.44
US$72,267 		2,841 -7.3% 25.44 US$72,267
2025-11-18 2025-11-17 PlS Planned sale
Ceesay Abraham

Chief Executive Officer

Executive Director
2,242 -5.5%
24.91
US$55,850 		2,242 -5.5% 24.91 US$55,850
2025-11-18 2025-11-17 PlS Planned sale
Ceesay Abraham

Chief Executive Officer

Executive Director
3,056 -0.5%
25.43
US$77,715 		3,056 -0.5% 25.43 US$77,715
2025-11-18 2025-11-17 PlS Planned sale
Ceesay Abraham

Chief Executive Officer

Executive Director
2,777 -0.5%
24.92
US$69,216 		2,777 -0.5% 24.92 US$69,216
2025-10-16 2025-10-15 PlS Planned sale
Ceesay Abraham

Chief Executive Officer

Executive Director
755 -1.8%
26.17
US$19,760 		755 -1.8% 26.17 US$19,760
2025-10-16 2025-10-15 PlS Planned sale
Ceesay Abraham

Chief Executive Officer

Executive Director
4,328 -9.4%
25.75
US$111,429 		4,328 -9.4% 25.75 US$111,429
2025-10-16 2025-10-15 PlS Planned sale
Ceesay Abraham

Chief Executive Officer

Executive Director
1,186 -0.2%
26.14
US$31,001 		1,186 -0.2% 26.14 US$31,001
Explore more

More insider trading research around Rapport Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America